BackBionano Genomics Overview

Bionano Genomics Total Current Liabilities

Track Bionano Genomics's total current liabilities ($10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$10.04M
↓ 58.48% YoYΔ $-14.14M vs prior year quarter

Peer trimmed avg / median

Loading

Bionano Genomics Total Current Liabilities History

Loading

Bionano Genomics vs. peers: Total Current Liabilities Comparison

Loading

Bionano Genomics Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bionano Genomics (BNGO) FAQ

As of the most recent data (June 2026), BNGO shows a total current liabilities of $10M. That compares with $24M in the prior-year period — down 58.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BNGO's total current liabilities is now $10M (was $24M) — a 58.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Bionano Genomics is outperforming or lagging.

Tracking BNGO's total current liabilities over time shows whether Bionano Genomics is scaling, shrinking, or reshaping that part of the business. The current reading is $10M That compares with $24M in the prior-year period — down 58.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has Bionano Genomics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $10M) with ownership activity and broader fundamentals.

Bionano Genomics's total current liabilities is $10M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.